Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice

Vaccine
M SinghD O'Hagan

Abstract

Hepatitis B surface antigen (HBsAg) was encapsulated in microparticles prepared from polylactide-co-glycolide (PLG) and polylactide (PLA) polymers using a solvent evaporation process. The immunoreactivity of the entrapped antigen was investigated by SDS-PAGE and Western blot. The microencapsulation process was modified to obtain both small (< 10 microns) and large microparticles (10-100 < microns). 80% of the antigen was encapsulated. Various combinations of small and large microparticles with controlled release characteristics were investigated in CD1 mice. Groups of animals were immunized with 30 micrograms equivalent of HBsAg in microparticles per animals. The control group received, three injections of 10 micrograms of HBsAg on alum at 0, 1 and 6 months. Results indicated that a single injection of HBsAg in microparticles could maintain the antibody response at a level comparable to the three-injection alum schedule for at least 1 year. An in vitro inhibition assay was developed to demonstrate that antigen-antibody reactivity were comparable for the microparticle immunized mice and the alum immunized mice. A competition assay with a monoclonal antibody specific for the neutralizing epitope of HBsAg demonstrated comparable b...Continue Reading

Citations

Jun 1, 1986·Vaccine·A Roumeliotou-KarayannisG Papaevangelou
Jul 9, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Dilip PawarK S Jaganathan
Jan 16, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shaobing ZhouHeming Li
Jun 6, 2000·Advanced Drug Delivery Reviews·R LangerJ Hanes
Jan 23, 1999·Vaccine·W Jilg
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·P JohansenB Gander
Jul 11, 2012·Journal of Pharmaceutical Sciences·Maria A MillerJennifer A Maynard
Jan 17, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jean-Pierre AmorijWim Jiskoot
May 17, 2011·Drug Discovery Today·Marie-Luce De TemmermanStefaan C De Smedt
May 5, 2011·International Journal of Pharmaceutics·Shailja TiwariSuresh P Vyas
Mar 11, 2009·Advanced Drug Delivery Reviews·Yogita Krishnamachari, Aliasger K Salem
Jul 22, 2008·Nanomedicine : Nanotechnology, Biology, and Medicine·Dhruba J BharaliYasmin Thanavala
Aug 9, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kevin J McHughAna Jaklenec
Mar 7, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Li FengTsuneji Nagai
Nov 26, 2010·Expert Review of Vaccines·Antu K Dey, Indresh K Srivastava
Oct 13, 2007·Expert Review of Vaccines·Manmohan SinghDerek O'Hagan
Feb 14, 2003·Biotechnology and Bioengineering·Chiara SchiraldiMario De Rosa
Nov 22, 2005·Expert Opinion on Drug Delivery·George MutwiriLorne A Babiuk
Oct 16, 2004·The Journal of Pharmacy and Pharmacology·K S JaganathanSuresh P Vyas
Nov 29, 2017·Artificial Cells, Nanomedicine, and Biotechnology·Hitesh Kumar DewanganSanjay Singh
Nov 29, 2007·Journal of Drug Targeting·Prem N GuptaSuresh P Vyas
Mar 26, 2010·Journal of Drug Targeting·Neeraj MishraSuresh P Vyas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioremediation (ASM)

Bioremediation is the treatment and removal of harmful pollutants or contaminants through the use of microorganisms. Discover the latest research here.